Epstein-Barr Virus Latent Membrane Protein 2 (EBV LMP2) (AA 1-147) 抗体 (HRP)
Quick Overview for Epstein-Barr Virus Latent Membrane Protein 2 (EBV LMP2) (AA 1-147) 抗体 (HRP) (ABIN7141319)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-147
-
Virus Strain
- strain B95-8
-
原理
- LMP2 Antibody, HRP conjugated
-
交叉反应
- Epstein-Barr Virus (EBV)
-
纯化方法
- Protein G purified
-
纯度
- >95 %
-
免疫原
- Recombinant Epstein-Barr virus Latent membrane protein 2 protein (1-147AA)
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Epstein-Barr Virus Latent Membrane Protein 2 (EBV LMP2)
-
别名
- Epstein-Barr virus (strain B95-8) (HHV-4) (Herpex simplex 4) LMP2
-
背景
-
Background: Isoform LMP2A maintains EBV latent infection of B-lymphocyte, by preventing lytic reactivation of the virus in response to surface immunoglobulin (sIg) cross-linking. Acts like a dominant negative inhibitor of the sIg-associated protein tyrosine kinases, LYN and SYK. Also blocks translocation of the B-cell antigen receptor (BCR) into lipid rafts, preventing the subsequent signaling and accelerated internalization of the BCR upon BCR cross-linking. Serves as a molecular scaffold to recruit SYK, LYN and E3 protein-ubiquitin ligases, such as ITCH and NEDD4L, leading to ubiquitination and potential degradation of both tyrosines kinases. Possesses a constitutive signaling activity in non-transformed cells, inducing bypass of normal B lymphocyte developmental checkpoints allowing immunoglobulin-negative cells to colonize peripheral lymphoid organs.
Aliases: LMP2 antibody, Latent membrane protein 2 antibody, Terminal protein antibody
-
UniProt
- P13285
抗原
-